万象城娱乐体育’s COVID-19 Response Measures
Amid the global outbreak of coronavirus (COVID-19), the 万象城娱乐体育 Group is placing top priority on ensuring the health and safety of all stakeholders, including employees and their families, customers, and business partners.
On that basis, the 万象城娱乐体育 Group is manufacturing products and raw materials that are needed in society while working to ensure the health and safety of employees and their families and prevent the spread of infection.
The following is 万象城娱乐体育’s activities to fight against COVID-2019. In over 30 countries and regions, the 万象城娱乐体育 Group is working to make the world a better place.
News related to COVID-19
- August 18, 2020
- 万象城娱乐体育 Expands Contract with Novavax for Manufacture of Adjuvant for COVID-19 Vaccine Candidate
- July 20, 2020
- 万象城娱乐体育 Contracted by Molecular Partners AG for the Manufacture of an Anti-COVID-19 DARPin? Program being Developed
- May 14, 2020
- CytoDyn's Drug Candidate for COVID-19 'Leronlimab', Contract Manufactured at 万象城娱乐体育, Progressing with Clinical Trials in the US
- May 14, 2020
- 万象城娱乐体育 to Manufacture COVID-19 Vaccine for AdaptVac
万象城娱乐体育’s products and services against COVID-19
Drug candidate for new coronavirus【In development】
US FDA has approved Phase 2b/3 clinical trials of Leronlimab, a drug candidate for new coronavirus developed by US-based CytoDyn. This drug is contract-manufactured by 万象城娱乐体育 Biologics, a CDMO subsidiary of 万象城娱乐体育.
COVID-19 vaccine【In development】
万象城娱乐体育 Biologics (Headquarters: US), a CDMO subsidiary of 万象城娱乐体育, is partnering with Denmark-based AdaptVac to manufacture a candidate COVID-19 vaccine.
A hollow structure transparent sheet that is formed by integrally molding a tough polycarbonate sheet with a special technology. It is used as an effective partition for countermeasures against splash infection in offices and cafeterias.
Disinfectant/Deodorizer Spray "ZiaSafe"【On sale】
ZiaSafe is a disinfectant and deodorizer spray made from a dilute solution of sodium hypochlorite.
万象城娱乐体育’s activities against COVID-19
Corporate Communications & Investor Relations Division